Additionally, the 36-month beta value for ELAN is 1.40. There are mixed opinions on the stock, with 4 analysts rating it as a “buy,” 1 rating it as “overweight,” 6 rating it as “hold,” and 0 rating it as “sell.”
The public float for ELAN is 488.20M and currently, short sellers hold a 2.48% ratio of that float. The average trading volume of ELAN on September 30, 2024 was 5.72M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ELAN) stock’s latest price update
Elanco Animal Health Inc (NYSE: ELAN) has experienced a rise in its stock price by 4.30 compared to its previous closing price of 13.73. However, the company has seen a gain of 1.78% in its stock price over the last five trading days. accesswire.com reported 2024-09-29 that LOS ANGELES, CA / ACCESSWIRE / September 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Elanco Animal Health Incorporated (“Elanco” or “the Company”) (NYSE:ELAN) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
ELAN’s Market Performance
Elanco Animal Health Inc (ELAN) has experienced a 1.78% rise in stock performance for the past week, with a -5.98% drop in the past month, and a -0.76% drop in the past quarter. The volatility ratio for the week is 4.23%, and the volatility levels for the past 30 days are at 4.18% for ELAN. The simple moving average for the last 20 days is -2.03% for ELAN’s stock, with a simple moving average of -5.17% for the last 200 days.
Analysts’ Opinion of ELAN
Many brokerage firms have already submitted their reports for ELAN stocks, with Morgan Stanley repeating the rating for ELAN by listing it as a “Equal-Weight.” The predicted price for ELAN in the upcoming period, according to Morgan Stanley is $15 based on the research report published on September 19, 2024 of the current year 2024.
Stifel, on the other hand, stated in their research note that they expect to see ELAN reach a price target of $20, previously predicting the price at $13. The rating they have provided for ELAN stocks is “Buy” according to the report published on January 05th, 2024.
Jefferies gave a rating of “Buy” to ELAN, setting the target price at $17 in the report published on December 19th of the previous year.
ELAN Trading at 2.53% from the 50-Day Moving Average
After a stumble in the market that brought ELAN to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -23.83% of loss for the given period.
Volatility was left at 4.18%, however, over the last 30 days, the volatility rate increased by 4.23%, as shares sank -6.34% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +11.27% upper at present.
During the last 5 trading sessions, ELAN rose by +1.78%, which changed the moving average for the period of 200-days by +12.67% in comparison to the 20-day moving average, which settled at $14.57. In addition, Elanco Animal Health Inc saw -3.89% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ELAN starting from Harrington Michael J, who purchase 3,500 shares at the price of $14.85 back on Aug 22 ’24. After this action, Harrington Michael J now owns 81,094 shares of Elanco Animal Health Inc, valued at $51,974 using the latest closing price.
Simmons Jeffrey N, the PRESIDENT, CEO AND DIRECTOR of Elanco Animal Health Inc, purchase 100,000 shares at $13.01 during a trade that took place back on Aug 12 ’24, which means that Simmons Jeffrey N is holding 145,000 shares at $1,300,610 based on the most recent closing price.
Stock Fundamentals for ELAN
Current profitability levels for the company are sitting at:
- 0.06 for the present operating margin
- 0.52 for the gross margin
The net margin for Elanco Animal Health Inc stands at -0.28. The total capital return value is set at 0.02. Equity return is now at value -18.78, with -8.49 for asset returns.
Based on Elanco Animal Health Inc (ELAN), the company’s capital structure generated 0.49 points at debt to capital in total, while cash flow to debt ratio is standing at 0.1. The debt to equity ratio resting at 0.96. The interest coverage ratio of the stock is 0.99.
Currently, EBITDA for the company is 945.0 million with net debt to EBITDA at 5.93. When we switch over and look at the enterprise to sales, we see a ratio of 2.75. The receivables turnover for the company is 4.16for trailing twelve months and the total asset turnover is 0.33. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.93.
Conclusion
In conclusion, Elanco Animal Health Inc (ELAN) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
